Network origin in Phil Walker first degree
Entity | Entity type | Industry | |
---|---|---|---|
Tetris Pharma Ltd.
Tetris Pharma Ltd. Medical DistributorsDistribution Services Part of Arecor Therapeutics Plc, Tetris Pharma Ltd. is a British company that sells and distributes pharmaceutical products. The company is based in Marlow, UK. The CEO of the company is Shafiq Choudhary. Tetris Pharma was acquired by Arecor Therapeutics Plc on August 04, 2022 for $7.33 million.
2
| Subsidiary | Medical Distributors | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Phil Walker via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Lab 21 Ltd.
Lab 21 Ltd. Medical/Nursing ServicesHealth Services Lab 21 Ltd. operates as a healthcare diagnostics company. It specializes in providing patients, doctors, hospitals ,and healthcare providers with diagnostic information for disease identification, disease predisposition, and personalized medicine, to help in managing health problems. It also offers diagnostic products and services and supports blood bank screening, medical diagnostics, and drug discovery. The company was founded in April 2005 by Berwyn E. Clarke and is headquartered in Cambridge, the United Kingdom. | Medical/Nursing Services | Director of Finance/CFO | |
Serco, Inc.
Serco, Inc. Information Technology ServicesTechnology Services Serco, Inc. provides services and project management support services. It specializes in fleet management, transportation, information technology and business consulting, engineering, human resources, and logistics services. The firm also offers human capital management, systems integration, lifecycle management, and economic cost analysis solutions. The company was founded in 1988 and is headquartered in Reston, VA. | Information Technology Services | Corporate Officer/Principal | |
Nokia UK Ltd.
Nokia UK Ltd. Specialty TelecommunicationsCommunications Nokia (UK) Ltd. distributes mobile phones and fixed telecom networks. It provides wireless data and mobile communications, information technology, and media services. The firm also provides mobile games, multimedia, and enterprise solutions to customers. The company was founded in 1990 and is headquartered in Huntingdon, the United Kingdom. | Specialty Telecommunications | Corporate Officer/Principal | |
McCann Erickson (Germany)
McCann Erickson (Germany) Miscellaneous Commercial ServicesCommercial Services McCann Erickson (Germany) provides brand communication and public relation services. The private company is based in Frankfurt, Germany. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
ALLIANCE PHARMA PLC | Pharmaceuticals: Major | Director of Finance/CFO | |
Genesis Technical Systems (UK) Ltd.
Genesis Technical Systems (UK) Ltd. Specialty TelecommunicationsCommunications Genesis Technical Systems (UK) Ltd. provides broadband technologies and internet for mobile telecom operators. It solutions include copper backhaul, the last mile, rural broadband and small cell backhaul. The firm products include mBond and DSL Rings. The company was founded by Stephen Peter Cooke in 2007 and is headquartered in Coventry, the United Kingdom. | Specialty Telecommunications | Director of Finance/CFO | |
MYHEALTHCHECKED PLC | Medical Specialties | Director of Finance/CFO | |
Ieso Digital Health Ltd.
Ieso Digital Health Ltd. Commercial Printing/FormsCommercial Services Ieso Digital Health Ltd. provides Internet enabled mental health services to health providers, private individuals and businesses. The firm engages in delivering cognitive behavioral therapy. It offers anxiety, bereavement, child and family, depression, drug and alcohol misuse, eating disorder, managing anger, managing pain, obsessive compulsive disorder, panic, phobia, post traumatic stress, relationship, sexual difficulty, sports psychology, stress management, and terminal illness therapy services. The company was founded by Barnaby Perks, Sue Wright and Nadine Field in 2000 and is headquartered in Cambridge, the United Kingdom. | Commercial Printing/Forms | Director of Finance/CFO | |
Akamis Bio Ltd.
Akamis Bio Ltd. BiotechnologyHealth Technology Akamis Bio Ltd. operates as a biotechnology company which develops novel therapeutics that addresses cancer and other clinically unmet diseases. Its products include Enadenotucirev, Espindolol and AbEnAd. The firm also develops treatments based upon the research phase vaccine platform PolySTAR, which combines recombinant viral vectors with polymers to shield them from the immune system, and the research phase adjuvant and immunotherapeutic platform PolyMAP, which combines polymers with synthetic adjuvants to significantly enhance the effectiveness of vaccines. The company was founded by Andrew Justin Stewart Coats and Stefan D. Anker on November 17, 2006 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Director of Finance/CFO | |
NUFORMIX PLC | Biotechnology | Director/Board Member | |
Arquer Diagnostics Ltd.
Arquer Diagnostics Ltd. Medical/Nursing ServicesHealth Services Arquer Diagnostics Ltd. develops proprietary diagnostic immunoassays for the detection of prostate and bladder cancer using urine samples. Its develops non-invasive, urine-based ELISA and Point-of Care tests meet the increased demand for cost-effective healthcare technologies that not only enhance patient care but help to reduce overall healthcare costs by improving patient outcomes. The firm will commercialise ELISA and point-of-care urine tests for prostate and bladder cancer for use in the urology clinic, hospital lab and the GP’s surgery. The company was founded by David Nicholas Miller-Jones and William Dawson in 2007 and is headquartered in Sunderland, the United Kingdom. | Medical/Nursing Services | Director of Finance/CFO | |
Nuformix Technologies Ltd.
Nuformix Technologies Ltd. Pharmaceuticals: MajorHealth Technology Nuformix Technologies Ltd. engages in investment in pharmaceutical products. Its activities include development and discovery of patented novel cocrystal forms of approved small molecules, creating an IP portfolio containing 14 granted patents covering cocrystal forms of five small molecule drugs. It offers the NXP001 and NXP002. The company was founded by Dr. David Joszef Tapolzcay and Dr. Daniel Gooding on October 23, 2007 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member |
Statistics
International
United Kingdom | 11 |
United States | 2 |
Germany | 2 |
Sectoral
Health Technology | 6 |
Health Services | 3 |
Communications | 3 |
Commercial Services | 3 |
Technology Services | 2 |
Operational
Director of Finance/CFO | 8 |
Corporate Officer/Principal | 3 |
Director/Board Member | 3 |
Chairman | 1 |
Most connected contacts
Insiders | |
---|---|
Madeleine Kennedy | 13 |
Leslie Galloway | 1 |
- Stock Market
- Insiders
- Phil Walker
- Company connections